Table of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Veterinary Vaccines Market to 2017: Executive Summary
2.1 The Global Veterinary Vaccines Market Will Witness Consistent Growth with Europe to Continue to Dominate
2.2 The Bovine Vaccines Market is the Largest Market Due to the Organized Dairy and Beef Producing Sectors
2.3 The Ovine Vaccines Market is One of the Fastest Growing Veterinary Vaccines Markets in the US, With an Estimated Growth Rate of 4% between 2010 and 2017
3 Veterinary Vaccines Market to 2017: Introduction
3.1 GBI Research Report Guidance
4 Veterinary Vaccines Market to 2017: Market Overview
4.1 Revenue Forecasts
4.2 Drivers
4.2.1 Livestock Owners Developing Increased Disease Awareness for Farm Animals
4.3 Barriers
4.3.1 Mutant Strains of Virus Pose a Challenge in Vaccine Manufacturing
4.3.2 Decrease in Cattle Population is Reducing the Demand for Vaccines
5 Veterinary Vaccines Market to 2017: Geographical Landscape
5.1 The US
5.1.1 Revenue Forecast
5.2 Europe
5.2.1 Revenue Forecast
5.3 Japan
5.3.1 Revenue Forecast
6 Veterinary Vaccines Market to 2017: Bovine Vaccines Market
6.1 The US
6.1.1 Revenue Forecasts
6.1.2 Annual Cost of Vaccination
6.1.3 Target Population
6.2 Europe
6.2.1 Revenue Forecasts
6.2.2 Annual Cost of Vaccination
6.2.3 Target Population
6.3 Japan
6.3.1 Revenue Forecasts
6.3.2 Annual Cost of Vaccination
6.3.3 Target Population
7 Veterinary Vaccines Market to 2017: Ovine Vaccines Market
7.1 The US (Sheep Vaccines Market)
7.1.1 Revenue Forecasts
7.1.2 Annual Cost of Vaccination
7.1.3 Target Population
7.2 Europe (Sheep Vaccine Market)
7.2.1 Revenue Forecasts
7.2.2 Annual Cost of Vaccination
7.2.3 Target Population
7.3 Japan (Sheep Vaccines Market)
7.3.1 Revenue Forecasts
7.3.2 Annual Cost of Vaccination
7.3.3 Target Population
7.4 The US (Goat Vaccines Market)
7.4.1 Revenue Forecasts
7.4.2 Annual Cost of Vaccination
7.4.3 Target Population
7.5 Europe (Goat Vaccines Market)
7.5.1 Revenue Forecasts
7.5.2 Annual Cost of Vaccination
7.5.3 Target Population
7.6 Japan (Goat Vaccines Market)
7.6.1 Revenue Forecasts
7.6.2 Annual Cost of Vaccination
7.6.3 Target Population
8 Veterinary Vaccines Market to 2017: Porcine Vaccines Market
8.1 The US
8.1.1 Revenue Forecasts
8.1.2 Annual Cost of Vaccination
8.1.3 Target Population
8.2 Europe
8.2.1 Revenue Forecasts
8.2.2 Annual Cost of Vaccination
8.2.3 Target Population
8.3 Japan
8.3.1 Revenue Forecasts
8.3.2 Annual Cost of Vaccination
8.3.3 Target Population
9 Veterinary Vaccines Market to 2017: Equine Vaccines Market
9.1 The US
9.1.1 Revenue Forecasts
9.1.2 Annual Cost of Vaccination
9.1.3 Target Population
9.2 Europe
9.2.1 Revenue Forecasts
9.2.2 Annual Cost of Vaccination
9.2.3 Target Population
9.3 Japan
9.3.1 Revenue Forecasts
9.3.2 Annual Cost of Vaccination
9.3.3 Target Population
10 Veterinary Vaccines Market to 2017: Competitive Landscape
10.1 Company Profiles
10.1.1 Bayer HealthCare
10.1.2 Pfizer
10.1.3 Merck Inc.
10.1.4 Novartis
11 Veterinary Vaccines Market to 2017: Product Profiles
11.1 Bovine Vaccines
11.1.1 Alpha-7
11.1.2 Vira Shield 6 + VL5
11.1.3 Salmonella Newport Bacterial Extract SRP
11.1.4 Imrab Large Animal
11.1.5 Anthrax Spore Vaccine
11.1.6 J-5 E. Coli Bacterin
11.2 Ovine Vaccines
11.2.1 Ultrabac 7
11.2.2 Ultrabac CD
11.2.3 Clostri Shield 7
11.3 Porcine Vaccines
11.3.1 Parvo Shield L5E
11.3.2 Porcine Pili Shield+C
11.3.3 LitterGuard LT-C
11.3.4 Farrowsure Gold B
11.4 Equine Vaccines
11.4.1 Recombitek Equine West Nile Virus Vaccine
11.4.2 Fluvac Innovator 6
11.4.3 Prestige V + VEE
11.4.4 Potomavac
11.4.5 Imrab 3
12 Veterinary Vaccines Market to 2017: Mergers & Acquisitions
12.1 Phibro Animal Health Completed Acquisition of Abic Animal Health in February 2009
12.2 Ceva Acquired Vetech Laboratories in October 2011
12.3 Ceva Acquired CentaurVA Animal Health in October 2011
12.4 Harbin Pharma Acquired Pfizer’s Swine Vaccine Business in June 2010
12.5 Boehringer Ingelheim Animal Health Acquires a Significant Portion of the Fort Dodge Animal Health Business from Pfizer in October 2009
12.6 Pfizer Acquired Microtek International in May 2010
12.7 Virbac Acquired Certain Veterinary Products from Pfizer in February 2010
13 Veterinary Vaccines Market to 2017: Licensing Agreements
13.1 Heska Corporation Amends Bovine Vaccine Agreement with AgriLabs
13.2 Pfizer Animal Health Inks Global Licensing Deal with Epitopix
13.3 GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
13.4 Vical Enters into Agreement with Japanese Partner for Veterinary Pandemic Influenza Vaccine
14 Veterinary Vaccines Market to 2017: Recent Activities
14.1 Intervet’s Equine West Nile Vaccine Approved by USDA (United States Department of Agriculture)
14.2 Defra Launched Bovine Tuberculosis Vaccine
14.3 Boehringer Ingelheim Vetmedica Receives Approval for Express FP and Express Vaccines from the USDA
15 Veterinary Vaccines Market to 2017: Appendix
15.1 Market Definitions
15.2 Abbreviations
15.3 Research Methodology
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research
15.4 Therapeutic Landscape
15.4.1 Market Size by Geography
15.5 Geographical Landscape
15.6 Competitive Landscape
15.6.1 Expert Panel Validation
15.7 Contact Us
15.8 Disclaimer
15.9 Sources